SEC Filings | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
May 1, 2017	DEFA14A	Additional proxy soliciting materials - definitive	0000320017-17-000033.pdf 0000320017-17-000033.rtf View HTML
Apr 27, 2017	DEFA14A	Additional proxy soliciting materials - definitive	0000320017-17-000029.pdf 0000320017-17-000029.rtf View HTML
Apr 27, 2017	4	Statement of changes in beneficial ownership of securities	0001144204-17-022653.pdf 0001144204-17-022653.rtf 0001144204-17-022653.xls View HTML
Apr 27, 2017	4	Statement of changes in beneficial ownership of securities	0001144204-17-022654.pdf 0001144204-17-022654.rtf 0001144204-17-022654.xls View HTML
Apr 27, 2017	4	Statement of changes in beneficial ownership of securities	0001144204-17-022656.pdf 0001144204-17-022656.rtf 0001144204-17-022656.xls View HTML
Apr 27, 2017	4	Statement of changes in beneficial ownership of securities	0001144204-17-022666.pdf 0001144204-17-022666.rtf 0001144204-17-022666.xls View HTML
Apr 27, 2017	DEFA14A	Additional proxy soliciting materials - definitive	0000320017-17-000031.pdf 0000320017-17-000031.rtf View HTML
Apr 11, 2017	DEFM14A	Definitive proxy statement relating to merger or acquisition	0001571049-17-003364.pdf 0001571049-17-003364.rtf 0001571049-17-003364.xls View HTML
Mar 31, 2017	PREM14A	A preliminary proxy statement relating to a merger or acquisition	0001571049-17-003097.pdf 0001571049-17-003097.rtf 0001571049-17-003097.xls View HTML
Mar 30, 2017	8-K	Report of unscheduled material events or corporate event	0000320017-17-000027.pdf 0000320017-17-000027.rtf 0000320017-17-000027.xls View HTML

Data provided by Kaleidoscope.